Alignment Healthcare (ALHC) Projected to Post Quarterly Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is expected to be posting its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $1.0034 billion for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:00 PM ET.

Alignment Healthcare Stock Down 3.4%

NASDAQ ALHC opened at $19.90 on Tuesday. The stock’s 50 day simple moving average is $21.03 and its 200 day simple moving average is $18.42. Alignment Healthcare has a one year low of $11.63 and a one year high of $23.87. The firm has a market cap of $3.98 billion, a PE ratio of -165.83, a price-to-earnings-growth ratio of 5.25 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on ALHC shares. Piper Sandler increased their target price on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a report on Tuesday, January 6th. KeyCorp reiterated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 22nd. JPMorgan Chase & Co. raised their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a research report on Friday, January 30th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and an average target price of $23.95.

Insider Activity

In related news, President Dawn Christine Maroney sold 282,070 shares of the business’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $5,285,991.80. Following the completion of the sale, the president directly owned 1,385,167 shares of the company’s stock, valued at $25,958,029.58. The trade was a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO John E. Kao sold 605,648 shares of the firm’s stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $11,349,843.52. Following the completion of the transaction, the chief executive officer directly owned 2,234,294 shares in the company, valued at approximately $41,870,669.56. The trade was a 21.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 2,125,938 shares of company stock valued at $41,799,570. 6.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wellington Management Group LLP boosted its holdings in Alignment Healthcare by 26.9% during the fourth quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock worth $277,900,000 after buying an additional 2,981,166 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after acquiring an additional 79,268 shares during the last quarter. Invesco Ltd. grew its holdings in Alignment Healthcare by 38.9% during the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after purchasing an additional 1,735,962 shares during the period. 8 Knots Management LLC increased its stake in Alignment Healthcare by 6.4% in the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after purchasing an additional 300,409 shares in the last quarter. Finally, State Street Corp increased its stake in Alignment Healthcare by 14.3% in the fourth quarter. State Street Corp now owns 3,668,602 shares of the company’s stock valued at $72,455,000 after purchasing an additional 460,154 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.